Notably, a group from Philadelphia performed “a triple blow for cancer” whereby combination of anti-CTLA-4 Ab and radiotherapy with anti-PD-L1 Ab have demonstrated the effectiveness in impeding tumor immune escape through distinct mechanisms [56]. The gene discussed is CTLA4; the disease is cancer.